Please login to the form below
AMR
This page shows the latest AMR news and features for those working in and with pharma, biotech and healthcare.
New report reveals antibiotic underdosing could be leading cause of AMR in UK
AMR has been declared by WHO as one of the top ten threats to global public health. ... dose of the antibiotic to fight infection, further contributing to the global AMR crisis.
Latest news
-
First WHO Global Clinical Trial Forum develops joint vision to improve clinical research
Experts in areas including cancer, AMR and neurological diseases participated. The first-ever World Health Organization (WHO) Global Clinical Trial Forum has put forward a joint vision for sustainable clinical research
-
Study finds AI detects AMR faster than gold-standard testing
The method detected AMR with at least 80% accuracy on a per-cell basis, within 30 minutes. ... Published in Communications Biology, a combination of fluorescence microscopy and AI was successful in detecting antimicrobial resistance (AMR).
-
World AMR Awareness Week to focus on urgent actions needed to prevent AMR
Currently, the misuse and overuse of antimicrobials is one of the biggest drivers of AMR. ... to make commitments to tackle AMR and international agreed targets to accelerate action.
-
UK antibiotic subscription model found by OHE as key to supporting investment
The World Health Organization has declared antimicrobial resistance (AMR), when bacteria, viruses, fungi and parasites become resistant to antimicrobials, as one of the top ten threats to global public health.
-
WHO releases 13 interventions to help address antimicrobial resistance
The organisation has declared AMR as one of the top ten threats to global public health. ... centre, as well as enhance awareness and understanding of AMR among policymakers and the general public.
More from news
Approximately 20 fully matching, plus 48 partially matching documents found.
Latest Intelligence
-
Man vs microbe: the fight against antimicrobial resistance
combined efforts of policymakers, prescribers, public and pharmaceutical companies being vital in the fight against AMR. ... underway to address the challenge of AMR and understand payers’ perceptions on their impact.
-
Resisting the resistance
By 2050, the UN predicts that AMR will be the cause of 10 million deaths every year. ... Given the complex genetic factors underlying resistance, a deep and comprehensive insight into the genome is essential in tackling AMR.
-
Why diagnostics investments are crucial to win the AMR battle
AMR could take the lives of ten million people a year within three decades. ... They have been incentivised to develop these tests by the Longitude Prize on AMR.
-
World Antimicrobial Awareness Week 2022
affordable, safe and have a low AMR risk – represent at least 60% of overall antibiotic consumption by 2030. ... level European policymakers to discuss the development of new antibiotics and initiatives by national health authorities to fight AMR.
-
Creating the urgency and drive needed to tackle antimicrobial resistance
an important piece about preparing for the next health disaster, ‘which is, of course, AMR’. ... calling for “a fraction of the losses invested to empower research in [AMR]”.
More from intelligence
Approximately 1 fully matching, plus 16 partially matching documents found.
Latest appointments
-
Henry Skinner has been appointed as the first CEO of the AMR Action Fund
I am honoured to join the AMR Action Fund and its incredibly important mission. ... I am proud and excited to lead the AMR Action Fund in its efforts to tackle the global challenge of AMR.
More from appointments
Approximately 1 fully matching, plus 0 partially matching documents found.
Latest from PMHub
-
Man vs microbe: the fight against antimicrobial resistance
Antimicrobial resistance (AMR) affects millions of people globally, but addressing AMR poses a unique challenge – as encouraging and promoting manufacturers to invest in research and development of new antibiotics while simultaneously
-
Action on Anti-microbial resistance: Will the UK rise to the challenge
This puts AMR right up there with leading causes of death globally, including coronary artery disease, stroke and respiratory disease. ... New antimicrobials will offer limited relief from AMR without matching access and uptake of diagnostics.
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
Natl Geogr Mag. May 2015. https://www.nationalgeographic.com/science/article/oneill-amr-3. Accessed June 10, 2021. 28.
-
Hanover Communications
We are three years into the UK Government’s 20-Year Vision for Antimicrobial Resistance (AMR), and the Department of Health and Social Care recently launched a consultation for the next ... Is UK policy ambitious enough to drive innovation in AMR, and
-
Antibiotic resistance: The silent pandemic
Available at: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/784894/UK_AMR_5_year_national_action_plan.pdf. Accessed November 2019. Health Europa. Rapid diagnostic
More from PMHub
Approximately 1 fully matching, plus 7 partially matching documents found.
Subscribe to our email news alerts
- New Playbook Alert: Virtual Patient Engagement
- AbbVie to expand solid tumour portfolio with $10bn ImmunoGen acquisition
- UK Biobank reveals new data from world's largest genetic project
- New study finds dose of Mavenclad treatment could predict MS relapse risk
- Astellas shares positive 24-week results for non-hormonal menopause drug fezolinetant
- GSK global survey reveals misunderstandings about shingles in adults
No results were found
PMHub
Mednet Group
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...
Latest intelligence
- New Playbook Alert: Virtual Patient Engagement
- ...
- Millennials: the wellness generation
- Looking at the results from a global healthcare research study focusing on the patients of the future...
- The problem with clinical trials (and how virtual insight-gathering can help)
- While still the gold standard of research, clinical trials are often riddled with issues that limit their applicability to broader populations or delay market access....
